AbbVie Inc. (ABBV) – Don’t Believe the Hype: Check The Facts
3,224 institutions hold shares in AbbVie Inc. (ABBV), with 1.84M shares held by insiders accounting for 0.10% while institutional investors hold 69.86% of the company’s
Tag: AbbVie Inc.
AbbVie Inc. (ABBV) – Don’t Believe the Hype: Check The Facts
3,223 institutions hold shares in AbbVie Inc. (ABBV), with 1.84M shares held by insiders accounting for 0.10% while institutional investors hold 69.88% of the company’s
Which institution holds the most shares in AbbVie Inc. (ABBV)
3,221 institutions hold shares in AbbVie Inc. (ABBV), with 1.84M shares held by insiders accounting for 0.10% while institutional investors hold 69.90% of the company’s
Positives for AbbVie Inc. (ABBV) as stock gains in recent trading
AbbVie Inc. (NYSE: ABBV) is -1.81% lower on its value in year-to-date trading and has touched a low of $74.78 and a high of $113.41
AbbVie Inc. (ABBV) Review – Making Smarter Decisions
3,212 institutions hold shares in AbbVie Inc. (ABBV), with 1.84M shares held by insiders accounting for 0.10% while institutional investors hold 69.87% of the company’s
AbbVie Inc. (ABBV) – Don’t Believe the Hype: Check The Facts
2,979 institutions hold shares in AbbVie Inc. (ABBV), with 1.77M shares held by insiders accounting for 0.10% while institutional investors hold 70.07% of the company’s
News
AbbVie Inc. (ABBV) And CBAK Energy Technology Inc. (CBAT) Among Headliners
AbbVie Inc. (NYSE: ABBV) shares are 4.18% up in the year-to-date (YTD) period and have moved -3.69% or -$3.53 lower in the latest trading session.